Article in press-uncorrected proof Performance analysis of the ARCHITECT anti-cyclic citrullinated peptide antibody in the diagnosis of rheumatoid arthritis

@inproceedings{Hwang2010ArticleIP,
  title={Article in press-uncorrected proof Performance analysis of the ARCHITECT anti-cyclic citrullinated peptide antibody in the diagnosis of rheumatoid arthritis},
  author={Sang Mee Hwang and Jeong-Ok Kim and Young-Mi Yoo and Sue Shin and Jin Q. Kim and Myoung Hee Park and Eun Young Song},
  year={2010}
}
Background: Anti-cyclic citrullinated peptide (CCP) antibody is emerging as an important diagnostic marker for rheumatoid arthritis (RA). We evaluated the analytical and diagnostic performance of the ARCHITECT anti-CCP (Abbott Diagnostics), a new fully automated chemiluminescent microparticle immunoassay. Methods: Serum samples from 69 patients with RA and 86 non-RA patients were used to evaluate the performance of the ARCHITECT anti-CCP assay, and the results were compared with those of EliA… CONTINUE READING
0 Citations
19 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 19 references

erythematosus

  • AS Russell, A Devani, WP Maksymowych
  • LUPUS
  • 2009

Similar Papers

Loading similar papers…